After 12 weeks of treatment, the neuroprotective effects of THOP1, the OX40 signaling pathway, the ALS signaling pathway, and the methylglyoxal and neuroinflammatory signaling pathways were significantly changed. This evidence concerns the gene TNFRSF4 and amyotrophic lateral sclerosis.